SEC Filing Details

Document Details

Filing Date
Jan 26, 2024
Document Date
Jan 26, 2024
Form Description
SCHEDULE 13G - Description
Company
Bellerophon Therapeutics, Inc.
Issuer
BELLEROPHON THERAPEUTICS, INC.